Company Gets $1.6 Billion From U.S. Government for COVID-19 Vaccine
Novavax has never brought a product to market before
CRC Risk Down With ACEi, Angiotensin Receptor Blocker Use
5 percent reduction in adjusted hazard ratio risk with each single year increase in drug use
Health Expenditures Considerable for Asthma, COPD in U.S. Workers
Annualized total medical expenditures are $7 billion and $5 billion, respectively
Medical Management Alone Better for Brain AV Malformations
Risk of stroke or death up with medical management plus interventional therapy for unruptured AVM
HDHPs Up Disparities in Access to Care Among Cancer Survivors
Cost barriers increased for blacks, with 22.8 percent reporting they skipped medications to save money
Roughly 2 Million Americans Buy Prescriptions From Outside the Country
Patient education, stringent quality control measures necessary to ensure safe purchases
Treatment Up for U.S. Adults Who Screen Positive for Depression
Likelihood of receiving treatment increased in association with having any health insurance
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
2005 to 2016 Saw Increase in Skeletal Muscle Relaxant Use
Office visits with prescribed SMR nearly doubled; tripling in visits for continued SMR drug therapy
Promising Results for Experimental COVID-19 Vaccine in Early Testing
Preliminary findings show that 45 study volunteers who received either a low or medium dose had immune response
